Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
AAD, abdominal, acellular, adolescence, affinity, andB, andin, anytime, archaea, ATM, Automotive, Avigen, bacterial, Basilea, Benchtop, bloating, Blvd, Boca, bowel, Campylobacter, Cantor, catalyst, causally, CDC, CDM, characteristic, CMSC, colon, colonize, composed, compromised, confined, confirmatory, constipation, corrected, count, CSMC, database, depressing, Detroit, Diosynth, discovered, ECC, EGRX, expedited, explicit, exploit, expressly, fall, fight, Fitzgerald, flora, foodborne, forin, freely, FUJIFILM, gas, gestagen, ground, gut, home, HTBX, Ia, Ib, IBS, illegal, inappropriately, includeAMITIZA, infant, inhibiting, initiatein, Instruction, interferon, intestinal, intestine, inventor, Ironwood, irritable, Japanese, jejuni, jeopardize, Jersey, LaFontana, leaving, led, legacy, licensure, lieu, linaclotide, lubiprostone, mark, MD, methane, microbiome, microorganism, mixed, modulator, morbidity, motility, murine, Mylan, NASDAQ, NUSE, obesity, occurrence, ofClostridium, OfferingSM, opportunistic, overproduction, pathology, Philadelphia, Pimentel, predominant, presumption, primate, Raton, recipient, relief, republication, root, saleable, Saleen, San, satisfactoryin, shareholder, SIBO, SLNN, SM, Specimen, St, Ste, stool, subset, symptomatic, Synthon, Takeda, theory, topline, tradable, tradeable, turn, UK, Underwriting, underwritten, urgent, veterinary, visit, white, withAcinetobacter, XON
Removed:
absorbed, adjusted, allocated, Amex, attorney, bank, Baruch, beginning, Berman, Castle, ceased, combined, consisted, cover, derivative, device, diagnostic, discrete, dose, embedded, enterprise, entry, escrow, exemption, feature, Flom, floor, force, formation, fraction, freestanding, gastroretentive, goodwill, host, ingested, instituted, Intraperiod, Max, Meagher, microbiology, mobile, nerve, Netli, oriented, Paramount, poor, principle, proper, ratcheted, reclassified, reincorporated, relapsing, relation, remitting, resignation, Scholar, segment, Sensatex, Separation, ser, Skadden, Slate, solicitation, step, supervising, thirteen, writing, zinc
Filing tables
Filing exhibits
Related press release
TOVX similar filings
Filing view
External links
EXHIBIT 32.2
CERTIFICATION PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Synthetic Biologics, Inc. (the “Registrant”) hereby certifies, to such officer’s knowledge, that:
| (1) | the accompanying Annual Report on Form 10-K of the Registrant for the year ended December 31, 2013 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant. |
| Date: March 31, 2014 | ||
| By: | /s/ C. Evan Ballantyne | |
| Name: C. Evan Ballantyne | ||
| Title: Chief Financial Officer | ||
| (Principal Financial Officer) | ||